Patents by Inventor Cédric Pierre Vonarburg

Cédric Pierre Vonarburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nebultzation of immunoglobulin
    Patent number: 11471617
    Abstract: The invention relates to methods for generating an aerosol by nebulization of a composition comprising polyclonal immunoglobulin (Ig). The selection of an efficient membrane nebulizer and a composition optimized for nebulization with such membrane nebulizer results in a particularly efficient method of generating an aerosol for administration of Ig to the respiratory tract.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: October 18, 2022
    Assignees: CSL BEHRING AG, PARI PHARMA GMBH, MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Cédric Pierre Vonarburg, Karin Steinfuehrer, Ulrich Baumann
  • METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING ACUTE EXACERBATIONS WITH POLYCLONAL IMMUNOGLOBULIN
    Publication number: 20220025019
    Abstract: This invention is in the field of preventing or treating acute exacerbations in chronic lung diseases, such as chronic obstructive pulmonary disease and non-cystic fibrosis bronchiectasis, by administration of polyclonal immunoglobulin to the respiratory tract, in particular by direct application of an aerosolized composition comprising polyclonal immunoglobulin.
    Type: Application
    Filed: December 2, 2019
    Publication date: January 27, 2022
    Inventors: Cédric Pierre VONARBURG, Ilka SCHULZE
  • HAEMATOPOIETIC STEM CELL-GENE THERAPY FOR WISKOTT-ALDRICH SYNDROME
    Publication number: 20210316013
    Abstract: The present disclosure provides expression vectors comprising at least two nucleic acid sequences, namely a nucleic acid sequence encoding an anti-HPRT RNAi, and a nucleic acid sequence encoding a Wiskott-Aldrich Syndrome protein. In some embodiments, the expression vector is a self-inactivating lentiviral vector. In some embodiments, the Wiskott-Aldrich Syndrome protein is used to alleviate the pathologies associated with Wiskott-Aldrich Syndrome.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 14, 2021
    Inventors: Cédric Pierre Vonarburg, Ming Yan, Chi-Lin Lee, Chao-Guang Chen, Walid Jhan Azar
  • Methods for affecting infections
    Patent number: 10829542
    Abstract: The invention relates to methods promoting the aggregation of Salmonella bacteria in the gut of subjects, thereby providing immune exclusion and limiting bacterial entry, therefore reducing mucosal and systemic infection.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: November 10, 2020
    Assignees: CSL BEHRING AG, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Blaise Corthésy, Gilles Bioley, Cédric Pierre Vonarburg
  • METHODS FOR AFFECTING SALMONELLA INFECTIONS
    Publication number: 20190345229
    Abstract: The invention relates to methods promoting the aggregation of Salmonella bacteria in the gut of subjects, thereby providing immune exclusion and limiting bacterial entry, therefore reducing mucosal and systemic infection.
    Type: Application
    Filed: December 20, 2017
    Publication date: November 14, 2019
    Applicants: CSL BEHRING AG, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Blaise CORTHÉSY, Gilles BIOLEY, Cédric Pierre VONARBURG
  • NEBULIZATION OF IMMUNOGLOBULIN
    Publication number: 20170021114
    Abstract: The invention relates to methods for generating an aerosol by nebulization of a composition comprising polyclonal immunoglobulin (Ig). The selection of an efficient membrane nebulizer and a composition optimized for nebulization with such membrane nebulizer results in a particularly efficient method of generating an aerosol for administration of Ig to the respiratory tract.
    Type: Application
    Filed: April 2, 2015
    Publication date: January 26, 2017
    Applicant: CSL BEHRING AG
    Inventors: Cédric Pierre VONARBURG, Karin STEINFUEHRER, Ulrich BAUMANN
  • Treatment of mucositis with immunoglobulin
    Patent number: 9546209
    Abstract: The invention relates to compositions comprising immunoglobulin for use in the treatment of mucositis by topical application. In particular, the invention relates to compositions comprising J chain-containing IgA and secretory component for the treatment of mucositis.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: January 17, 2017
    Assignees: CSL Behring AG, Universitaet Bern
    Inventors: Christoph Aebi, Sonja Christina Lueer, Alexander Schaub, Sylvia Miescher, Adrian Zuercher, Cédric Pierre Vonarburg
  • TREATMENT OF MUCOSITIS WITH IMMUNOGLOBULIN
    Publication number: 20150030613
    Abstract: The invention relates to compositions comprising immunoglobulin for use in the treatment of mucositis by topical application. In particular, the invention relates to compositions comprising J chain-containing IgA and secretory component for the treatment of mucositis.
    Type: Application
    Filed: March 8, 2013
    Publication date: January 29, 2015
    Inventors: Christoph Aebi, Sonja Christina Lueer, Alexander Schaub, Sylvia Miescher, Adrian Zürcher, Cédric Pierre Vonarburg